-0%
New
For research use only. Not for human or veterinary use. Product information is provided for laboratory research reference.
- Independently tested
- Research use only
Tirzepatide
Dual GIP and GLP-1 receptor agonist peptide supplied as a lyophilised powder for metabolic and incretin research.
Strength
$95.00
Save 0%
CoAView certificate of analysis
COAComing soon
Description
Tirzepatide is a synthetic 39-amino-acid peptide that activates both the GIP and GLP-1 receptors. A C20 fatty-diacid side chain extends its half-life, making it a key reference compound in dual-incretin research.
Research focus
- GIP and GLP-1 receptor signalling
- Glucose and lipid metabolism research
- Comparative studies with single and triple agonists
Supplied as a lyophilised powder in a sealed vial. Available in 10 mg, 20 mg and 30 mg.
Each batch is independently tested, and the certificate of analysis matching the lot number on your vial is published on our COA page.
For laboratory research use only. Not for human or veterinary use.
- Same-day dispatch on business days Order before 2:00 pm AEDT on business days
- Free express shipping over $150 Tracked delivery Australia-wide
- Protected, discreet packaging Every vial cushioned and sealed
- Certificate for every batch Lot-matched, independently tested
Secure, encrypted checkout
Verified test results
Every batch, independently verified.
Each batch is tested by an independent laboratory before it ships. This is the report for the current batch.
JanoshikThird-party analysis
Certificate of analysis
99.864%
Purity by HPLC
View signed certificate (PDF)Quality panel 3 assays passed
- Peptide purityNot specified 99.864%Pass
- IdentityLC-MS Not explicitly confirmedPass
- Net peptide content32.22mg ReportedPass
Every batch on record
Open any lot’s certificate. Your order ships from a documented batch with its own lot-specific report.
-
Tirzepatide 30mg Latest
Lot #215500
99.864%HPLC purity · meets spec
- Labelled
- 30mg
- Measured
- 32.22mg
- Identity
- Not explicitly confirmed
- Tested
- 17 Aug 2026
3 assays passed · Janoshik
View certificate — Tirzepatide 30mg, #215500
Technical specifications
Compound information
Molecular profile
What is Tirzepatide?
Tirzepatide is a synthetic 39-amino-acid peptide that activates both the GIP and GLP-1 receptors. A C20 fatty-diacid side chain extends its half-life, making it a key reference compound in dual-incretin research.
Research focus
- GIP and GLP-1 receptor signalling
- Glucose and lipid metabolism research
- Comparative studies with single and triple agonists
Supplied as a lyophilised powder in a sealed vial. Available in 10 mg, 20 mg and 30 mg.
Each batch is independently tested, and the certificate of analysis matching the lot number on your vial is published on our COA page.
For laboratory research use only. Not for human or veterinary use.
- Type
- Synthetic peptide (GIP/GLP-1 receptor agonist)
- CAS number
- 2023788-19-2
- Molecular formula
- C225H348N48O68
- Molecular weight
- 4,813.5 g/mol
- Amino acids
- 39
- Fatty acid chain
- C20 diacid
Storage requirements
Stability information
- Lyophilised (sealed vial)−20 °C long-term, protected from light
- Reconstituted2–8 °C, use within 28 days
- In transitStable at ambient temperature for shipping
Product details
- Strength
- 10mg, 20mg, 30mg
- Purity
- ≥99% (HPLC)
- Form
- Lyophilised powder
- Current lot
- Category
- Metabolic Research, New Arrivals
You may also need
-
-
-0% New
-
-
